GC Genome Corporation (KOSDAQ:340450)
South Korea · Delayed Price · Currency is KRW 6,900.00
-100.00 (-1.43%)
Sep 18, 2026, 3:30 PM KST
GC Genome Market Cap
GC Genome has a market cap or net worth of 163.19 billion as of September 18, 2026. Its market cap has decreased by -14.92% in one year.
Market Cap
163.19B
Enterprise Value
124.91B
Revenue
32.64B
Ranking
n/a
PE Ratio
30.03
Stock Price
6,900.00
ChartMarket Cap Chart
Since June 11, 2025, GC Genome's market cap has decreased from 262.52B to 163.19B, a decrease of -37.84%. That is a compound annual growth rate of -31.20%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 163.19B | 1.17% |
| Dec 30, 2025 | 161.30B | -38.56% |
| Jun 11, 2025 | 262.52B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Genomictree | 250.11B |
| Bioneer | 237.45B |
| GC Cell | 207.98B |
| NeoImmuneTech | 196.15B |
| HLB Therapeutics | 180.68B |
| Anterogen.Co.,Ltd. | 151.69B |
| Helixmith | 137.22B |
| Genexine | 128.93B |